280
Participants
Start Date
March 31, 2003
Study Completion Date
December 31, 2008
chemotherapy
dexamethasone
plasmapheresis
Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke
Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham
Good Hope Hospital, Birmingham
Birmingham Heartlands Hospital, Birmingham
Bradford Royal Infirmary, Bradford
Sussex Cancer Centre at Royal Sussex County Hospital, Brighton
Bristol Haematology and Oncology Centre, Bristol
Addenbrooke's Hospital, Cambridge
Kent and Canterbury Hospital, Canterbury
St. Helier Hospital, Carshalton
Saint Richards Hospital, Chichester
Walsgrave Hospital, Coventry
Harrogate District Hospital, Harrogate
Wycombe General Hospital, High Wycombe
Hull Royal Infirmary, Hull
Leeds Cancer Centre at St. James's University Hospital, Leeds
Leicester General Hospital, Leicester
Aintree University Hospital, Liverpool
Saint Bartholomew's Hospital, London
St. Georges, University of London, London
Hammersmith Hospital, London
Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne
Nottingham City Hospital, Nottingham
Oxford Radcliffe Hospital, Oxford
Hope Hospital, Salford
Staffordshire General Hospital, Stafford
Sunderland Royal Hospital, Sunderland
Royal Cornwall Hospital, Truro, Cornwall
New Cross Hospital, Wolverhampton
Cancer Care Centre at York Hospital, York
Centre for Cancer Research and Cell Biology at Queen's University Belfast, Belfast
Aberdeen Royal Infirmary, Aberdeen
Monklands General Hospital, Airdrie
Dumfries & Galloway Royal Infirmary, Dumfries
Ninewells Hospital, Dundee
Edinburgh Cancer Centre at Western General Hospital, Edinburgh
Royal Infirmary - Castle, Glasgow
Morriston Hospital NHS Trust, West Glamorgen
Wrexham Maelor Hospital, Wrexham
University of Glasgow
OTHER